Transcriptomics

Dataset Information

0

ESR1 mutations maintain higher ER pathway activity relative to vehicle and ERa-WT controls following treatment with Raloxifene or fulvestrant.


ABSTRACT: The goal of the study was to understand whether mutations in ERa can promote resistance to various ERa antagonists of the SERD and SERM class. We found that ESR1 mutations can maintain higher ER pathway activity relative to control lines following short-term treatment with ERa antagonists raloxifene or fulvestrant.

ORGANISM(S): Homo sapiens

PROVIDER: GSE115564 | GEO | 2018/06/12

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA475477 | ENA
2022-08-01 | GSE190384 | GEO
2022-08-01 | GSE190385 | GEO
2015-08-07 | GSE71791 | GEO
2015-08-07 | E-GEOD-71791 | biostudies-arrayexpress
2019-07-25 | GSE117941 | GEO
2019-07-25 | GSE117940 | GEO
2023-09-11 | E-MTAB-13139 | biostudies-arrayexpress
2023-09-11 | E-MTAB-13113 | biostudies-arrayexpress
2012-12-05 | E-GEOD-35206 | biostudies-arrayexpress